descriptionPublicationkeyboard_double_arrow_right Article 01 May 2000 English Publisher:Elsevier BVJournal:Thrombosis Research, volume 98, pages 97-111 (issn: 0049-3848,

Authors: R P, Atkinson; C, DeLemos;

doi: 10.1016/s0049-3848(00)00212-7

pmid: 10812162

Acute Ischemic Stroke Management

- Summary
- Subjects
- Metrics

Abstract

The use of thrombolytic therapy represents one of many recent developments in the management of acute ischemic stroke. The development of stroke teams and protocols has been driven by these new demands for an urgent response to ischemic stroke. The short time window of 3 hours for therapy with intravenous recombinant tissue plasminogen activator requires efficient evaluation and treatment of stroke patients and also necessitates a rigorous approach to blood pressure management, electrolytes, fluids, and temperature. Anticoagulation has not been proven to safely prevent progression or early recurrence of stroke, but antiplatelet therapy is worthwhile.

Keywords

Stroke, Time Factors, Fibrinolytic Agents, Tissue Plasminogen Activator, Acute Disease, Humans, Thrombolytic Therapy, Tomography, X-Ray Computed, Brain Ischemia

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	5
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average